Executives Pay

anonymous

Guest
Harbaugh, Matthew
Mr. Matthew Harbaugh is Chief Financial Officer, Executive Vice President of Mallinckrodt Public Limited Company. He has executive responsibility for finance, procurement and information technology. Mr. Harbaugh previously served as Vice President, Finance of Covidien’s Pharmaceuticals business, a position he held from July 2008 until June 2013, when Mallinckrodt became an independent public company. He also served as Interim President of Covidien’s Pharmaceuticals business from November 2010 to January 2012. Mr. Harbaugh joined Covidien’s Pharmaceuticals business in August 2007 as its Vice President and Controller, Global Finance for the Global Medical Imaging business. Mr. Harbaugh was a Lead Finance Executive with Cerberus Capital Management, L.P., a New York-based private equity firm, from April 2007 until August 2007. Prior to that Mr. Harbaugh worked nearly ten years for Monsanto, where he held several positions, including corporate finance director, investor relations, and finance director/chief financial officer for Monsanto's Argentine/Chilean and Canadian operations via two expatriate assignments.

BASIC COMPENSATION
Total Annual Compensation, USD 570,000
Restricted Stock Awards, USD 3,731,410
Long-Term Incentive Plans, USD 2,845,520
All Other, USD 56,262
Fiscal Year Total, USD 7,203,190